The pharmaceutical landscape for blood sugar is shifting, and transdermal GLP-1 delivery systems represent a potential breakthrough. Unlike subcutaneous injections, this technique offers a less invasive way to deliver https://donnalbyi556160.livebloggs.com/47727194/glp-1-patches-a-novel-approach-to-glucose-management